BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8690824)

  • 1. Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic?
    Flockhart DA
    J Clin Psychopharmacol; 1996 Apr; 16(2):101-3. PubMed ID: 8690824
    [No Abstract]   [Full Text] [Related]  

  • 2. Terfenadine and SSRIs.
    Tafler G
    CMAJ; 1997 Oct; 157(8):1019. PubMed ID: 9347771
    [No Abstract]   [Full Text] [Related]  

  • 3. Terfenadine should be withdrawn from clinical use.
    Khilnani G
    J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long QT interval. Interaction of terfenadine and itraconazole].
    Rufke C; Nieber K
    Med Monatsschr Pharm; 2006 Jan; 29(1):22-4. PubMed ID: 16463550
    [No Abstract]   [Full Text] [Related]  

  • 5. Terfenadine therapy: can we justify the risks?
    Rangno R
    CMAJ; 1997 Jul; 157(1):37-8. PubMed ID: 9220940
    [No Abstract]   [Full Text] [Related]  

  • 6. Fexofenadine and prolonged QT intervals.
    Shuster J
    Nursing; 1999 Sep; 29(9):72. PubMed ID: 10540625
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on "Dextromethorphan-induced serotonin syndrome".
    Karamanakos PN; Panteli ES
    Clin Toxicol (Phila); 2008 Dec; 46(10):1101; author reply 1101-2. PubMed ID: 18946793
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe cardiac arrhythmia on fexofenadine?
    Prescrire Int; 2000 Feb; 9(45):212. PubMed ID: 11503802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsades de pointes from terfenadine and sotalol given in combination.
    Feroze H; Suri R; Silverman DI
    Pacing Clin Electrophysiol; 1996 Oct; 19(10):1519-21. PubMed ID: 8904547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias.
    Wynn RL
    Gen Dent; 1993; 41(1):27-9. PubMed ID: 7489857
    [No Abstract]   [Full Text] [Related]  

  • 11. Fexofenadine-induced QT prolongation: a myth or fact?
    Dhar S; Hazra PK; Malakar S; Mistri G
    Br J Dermatol; 2000 Jun; 142(6):1260-1. PubMed ID: 10848773
    [No Abstract]   [Full Text] [Related]  

  • 12. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
    Pinto YM; van Gelder IC; Heeringa M; Crijns HJ
    Lancet; 1999 Mar; 353(9157):980. PubMed ID: 10459910
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
    Takahara A; Sugiyama A; Hashimoto K
    Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What has the patient been taking?
    Pasco J
    Aust Fam Physician; 1998 Jun; 27(6):517. PubMed ID: 9648320
    [No Abstract]   [Full Text] [Related]  

  • 15. [Why is split the normal dose into half?].
    Wihl JA
    Lakartidningen; 1996 Jan; 93(4):229. PubMed ID: 8569339
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihistamines and the heart.
    Marquardt D
    West J Med; 1993 Jun; 158(6):613-4. PubMed ID: 8101675
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF; Pferferman A; Solé D; Naspitz CK
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
    Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
    Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions associated with terfenadine and related nonsedating antihistamines.
    Zechnich AD; Haxby DG
    West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic aspects of second-generation H1 antihistamines: a reply to Philpot.
    Estes KS; González MA
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):310-2. PubMed ID: 10395124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.